Literature DB >> 8159522

Antibiotic resistance of microorganisms involved in ear, nose and throat infections.

F Baquero1, E Loza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8159522     DOI: 10.1097/00006454-199401001-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  9 in total

1.  Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  B Barry; M Muffat-Joly; J Bauchet; F Faurisson; P Gehanno; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 2.  Therapy of acute otitis media. Clinical and economic aspects.

Authors:  R Sagraves; W Maish
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

3.  Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland.

Authors:  Thomas Jaecklin; Peter Rohner; Véronique Jacomo; Kurt Schmidheiny; Alain Gervaix
Journal:  Eur J Pediatr       Date:  2005-08-25       Impact factor: 3.183

Review 4.  Colonisation and infection with resistant gram-positive cocci. Epidemiology and risk factors.

Authors:  O Cars
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.

Authors:  S Chodosh; S Lakshminarayan; H Swarz; S Breisch
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

6.  Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics.

Authors:  A Barzilai; E Leibovitz; J H Laver; L Piglansky; S Raiz; M R Abboud; D M Fliss; A Leiberman; R Dagan
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

7.  Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children.

Authors:  J L Blumer; M D Reed; G L Kearns; R F Jacobs; W M Gooch; R Yogev; K Willims; B J Ewing
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

8.  Community prescribing and resistant Streptococcus pneumoniae.

Authors:  Galia Barkai; David Greenberg; Noga Givon-Lavi; Eli Dreifuss; Daniel Vardy; Ron Dagan
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

9.  Numerical optimization of targeted delivery of charged nanoparticles to the ostiomeatal complex for treatment of rhinosinusitis.

Authors:  Jinxiang Xi; Jiayao Eddie Yuan; Xiuhua April Si; James Hasbany
Journal:  Int J Nanomedicine       Date:  2015-07-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.